As of 2025-07-07, the Intrinsic Value of HAVN Life Sciences Inc (HAVN.CN) is -2.74 CAD. This HAVN.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.03 CAD, the upside of HAVN Life Sciences Inc is -9,239.57%.
Based on its market price of 0.03 CAD and our intrinsic valuation, HAVN Life Sciences Inc (HAVN.CN) is overvalued by 9,239.57%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -2.74 - -2.74 | -2.74 | -9,239.57% |
| P/E | (1.25) - (1.29) | (1.32) | -4487.0% |
| DDM - Stable | (7.19) - (114.55) | (60.87) | -203007.5% |
| DDM - Multi | 0.00 - 0.00 | 0.00 | -100.0% |
| Market Cap (mil) | 0.86 |
| Beta | 5.07 |
| Outstanding shares (mil) | 28.65 |
| Enterprise Value (mil) | 0.87 |
| Market risk premium | 5.10% |
| Cost of Equity | 6.38% |
| Cost of Debt | 5.00% |
| WACC | 5.04% |